Article Details

Adjuvant developed with NIH funding enhances efficacy of India's COVID-19 vaccine

Retrieved on: 2021-06-29 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Adjuvant developed with NIH funding enhances efficacy of India's COVID-19 vaccine. View article details on hiswai:

Excerpt

“Ending a global pandemic requires a global response,” said Anthony S. ... In addition, the alum in Alhydroxiquim-II stimulates the immune system to ...

Article found on: www.nih.gov

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo